The Current Burden of Follow-up of Stage 1A1 Cervical Cancer
Wendy Susan MacNab1, Tristan F Holdsworth, Rhona Lindsay
11Glasgow Royal Infirmary, Glasgow, United Kingdom; and 2Daisy Hill Hospital, Newry, Northern Ireland.
Insights
Stage 1A1 cervical cancer follow-up shows low recurrence rates after large loop excision of the transformation zone (LLETZ). Post-hysterectomy vault smears offer limited benefit in managing these patients.
Area of Science:
- Gynecologic Oncology
- Cervical Cancer Screening
- Public Health Surveillance
Background:
- Stage 1A1 cervical cancer represents an early stage of the disease.
- Effective follow-up strategies are crucial for patient management and recurrence detection.
- Assessing follow-up consistency is vital for optimizing healthcare resource allocation.
Purpose of the Study:
- To evaluate the current follow-up practices for stage 1A1 cervical cancer.
- To determine the consistency and effectiveness of post-treatment surveillance.
- To analyze recurrence rates and the utility of specific follow-up procedures.
Main Methods:
- Retrospective review of women diagnosed with stage 1A1 cervical cancer (2007-2011).
- Data collection included referral cytology, treatment method (large loop excision of the transformation zone - LLETZ), post-treatment cytology, and recurrence rates.
- Outcomes assessed: recurrence rate, abnormal cytology, and interventions during follow-up.
Main Results:
- 90% of stage 1A1 cervical cancers originated from abnormal screening cytology.
- Large loop excision of the transformation zone (LLETZ) was the definitive treatment for 43 out of 78 women.
- Post-LLETZ cytology was negative in almost 86% of cases, with only one recurrence observed. No significant abnormalities were found in post-hysterectomy vault smears.
Conclusions:
- Large loop excision of the transformation zone (LLETZ) is associated with a very low rate of abnormal cytology.
- Vault smears appear to have limited value in the follow-up management of women treated with hysterectomy for stage 1A1 cervical cancer.
Objective:
The aim of this study was to assess the current burden and consistency of stage 1A1 cervical cancer follow-up within Greater Glasgow and Clyde Health Board.
Methods:
A retrospective review was undertaken of women diagnosed with and treated of, between 2007 and 2011, stage 1A1 cervical cancer in Greater Glasgow and Clyde Health Board. Data were collected on referral cytology, definitive method of treatment, posttreatment cytology, and rate of recurrence. Outcomes included rate of recurrence, abnormal cytology, and number of interventions during follow-up.
Results:
Of the 78 women diagnosed with stage 1A1 cervical cancer, 43 had a LLETZ (large loop excision of the transformation zone) as definitive treatment. Ninety percent of stage 1A1 cervical cancers were diagnosed following abnormal screening cytology. Almost 86% of all cytology post-LLETZ were negative. Only 1 woman had a recurrence. No posthysterectomy vault smears were low-grade dyskaryosis or worse.
Conclusions:
There is a very low rate of abnormal cytology after LLETZ. Vault smears are of limited benefit in the management of women posthysterectomy for stage 1A1 cervical cancer.
More Related Videos
05:52Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019